Kymera Therapeutics Insider Trades
NASDAQ: KYMRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 95 · $304.25M
- Shares bought / sold
- 0 / 2.78M
- Net activity
- Net selling $304.3 million
Kymera Therapeutics insider activity
Over the last 12 months, Kymera Therapeutics insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 95 sales. Insiders bought $0 and sold $304.3 million worth of stock, for net insider selling of $304.3 million. The largest seller was BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK N, with $173.7 million in reported sales.
The most recent filing shows Mainolfi Nello (Chief Executive Officer) reporting a transaction in 30,000 shares at $2.08 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put KYMR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
KYMR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 262 | $30.42K | Form 4 |
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 8,230 | $949.74K | Form 4 |
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 7,601 | $869.78K | Form 4 |
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 4,876 | $552.16K | Form 4 |
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 5,506 | $618.98K | Form 4 |
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 3,525 | $392.83K | Form 4 |
| Oct 1, 2026 | Mainolfi NelloChief Executive Officer | Option exercise | 30,000 | $62.40K | Form 4 |
| Sep 4, 2026 | Adams BrianChief Legal Officer | Sale | 2,137 | $251.25K | Form 4 |
| Sep 4, 2026 | Adams BrianChief Legal Officer | Sale | 3,025 | $353.35K | Form 4 |
| Sep 4, 2026 | Adams BrianChief Legal Officer | Sale | 1,209 | $139.70K | Form 4 |
| Jul 27, 2026 | Rooney TerenceChief Medical Officer | Award | 38,000 | — | Form 4 |
| Jul 7, 2026 | Mainolfi NelloChief Executive Officer | Sale | 50,000 | $5.95M | Form 4 |
| Jul 7, 2026 | Mainolfi NelloChief Executive Officer | Option exercise | 50,000 | $104.00K | Form 4 |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 3,336 | $388.84K | Form 4 |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 44,050 | $5.10M | Form 4 |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 24,105 | $2.77M | Form 4 |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 6,626 | $755.20K | Form 4 |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer | Sale | 1,883 | $212.41K | Form 4 |
| Jul 1, 2026 | Mainolfi NelloChief Executive Officer | Option exercise | 80,000 | $166.40K | Form 4 |
| Jul 1, 2026 | Goodman NoahChief Business Officer | Sale | 3,389 | $387.33K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 3,200 | $376.65K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 6,153 | $719.86K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 7,971 | $923.18K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 51,375 | $5.90M | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 4,110 | $469.31K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 1,100 | $124.07K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 1,700 | $189.66K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Sale | 1,500 | $165.81K | Form 4 |
| Jun 30, 2026 | Jacobs Bruce N.Chief Financial Officer | Option exercise | 61,378 | $327.14K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 3,024 | $325.87K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 2,318 | $247.17K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 848 | $89.70K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 19,093 | $2.06M | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 14,613 | $1.56M | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 5,471 | $578.72K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 157 | $17.46K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 1,199 | $132.69K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 1,239 | $135.98K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 1,688 | $182.78K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 907 | $100.86K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 7,602 | $841.31K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 7,833 | $859.67K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 10,658 | $1.15M | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 130 | $14.46K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 1,078 | $119.30K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 1,104 | $121.16K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 1,498 | $162.20K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 2,698 | $290.74K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 2,133 | $227.44K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 770 | $81.45K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 934 | $103.86K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 7,723 | $854.70K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 7,968 | $874.49K | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 10,848 | $1.17M | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 19,419 | $2.09M | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 14,798 | $1.58M | Form 4 |
| Jun 29, 2026 | Booth BruceDirector | Sale | 5,549 | $586.97K | Form 4 |
| Jun 26, 2026 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK NDirector | Sale | 51,858 | $5.52M | Form 4 |
| Jun 26, 2026 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK NDirector | Sale | 113,289 | $12.07M | Form 4 |
| Jun 26, 2026 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK NDirector | Sale | 627,597 | $66.84M | Form 4 |
| Jun 26, 2026 | BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BVF I GP LLC & BIOTECHNOLOGY VALUE FUND II LP & BVF II GP LLC & Biotechnology Value Trading Fund OS LP & BVF Partners OS Ltd. & BVF GP HOLDINGS LLC & BVF INC/IL & LAMPERT MARK NDirector | Sale | 837,914 | $89.24M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 1,729 | $205.16K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 3,069 | $361.68K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 1,701 | $199.17K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 952 | $110.14K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 3,896 | $447.81K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 2,083 | $237.40K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 78 | $8.77K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 1,442 | $160.80K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 1,579 | $174.46K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 4,562 | $500.86K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 32,402 | $3.50M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 3,958 | $425.76K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 12,390 | $1.47M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 22,046 | $2.60M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 12,181 | $1.43M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 6,821 | $789.12K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 27,951 | $3.21M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 14,913 | $1.70M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 555 | $62.43K | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 10,366 | $1.16M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 11,277 | $1.25M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 32,624 | $3.58M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 231,007 | $24.98M | Form 4 |
| Jun 26, 2026 | Booth BruceDirector | Sale | 28,296 | $3.04M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 698 | $85.62K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 5,689 | $690.53K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 15,660 | $1.89M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 5,144 | $615.79K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 337 | $43.68K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 2,197 | $282.73K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 25,075 | $3.19M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 1,609 | $203.88K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 3,716 | $467.55K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 11,711 | $1.46M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 10,860 | $1.34M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 4,977 | $610.53K | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 40,774 | $4.95M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 112,299 | $13.55M | Form 4 |
| Jun 25, 2026 | Booth BruceDirector | Sale | 37,179 | $4.45M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4